FDA approval of Regeneron’s Eylea delayed by 3 months
TARRYTOWN, N.Y. (AP) — Earlier on Tuesday, Regeneron Pharmaceuticals Inc. announced that FDA review of the company’s experimental eye drug,
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine